352 related articles for article (PubMed ID: 12794788)
1. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
Brunner HI; Silverman ED; Bombardier C; Feldman BM
Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
5. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
6. Do lupus disease activity measures detect clinically important change?
Fortin PR; Abrahamowicz M; Clarke AE; Neville C; Du Berger R; Fraenkel L; Liang MH
J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
[TBL] [Abstract][Full Text] [Related]
7. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
8. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
9. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
10. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
11. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
Griffiths B; Mosca M; Gordon C
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.
Brunner HI; Higgins GC; Wiers K; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Klein-Gitelman MS; Seid M
J Rheumatol; 2009 Jul; 36(7):1536-45. PubMed ID: 19487266
[TBL] [Abstract][Full Text] [Related]
13. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
[TBL] [Abstract][Full Text] [Related]
15. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.
Ibañez D; Urowitz MB; Gladman DD
J Rheumatol; 2003 Sep; 30(9):1977-82. PubMed ID: 12966601
[TBL] [Abstract][Full Text] [Related]
16. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.
Ibañez D; Gladman DD; Urowitz MB
J Rheumatol; 2005 May; 32(5):824-7. PubMed ID: 15868616
[TBL] [Abstract][Full Text] [Related]
17. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
18. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
19. A trial of contraceptive methods in women with systemic lupus erythematosus.
Sánchez-Guerrero J; Uribe AG; Jiménez-Santana L; Mestanza-Peralta M; Lara-Reyes P; Seuc AH; Cravioto MD
N Engl J Med; 2005 Dec; 353(24):2539-49. PubMed ID: 16354890
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
Aldar H; Lapa AT; Bellini B; Sinicato NA; Postal M; Fernandes PT; Costallat LT; Marini R; Appenzeller S
Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
